Caxton Corp as of March 31, 2019
Portfolio Holdings for Caxton Corp
Caxton Corp holds 26 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Strongbridge Bioph shs usd | 30.6 | $33M | 6.6M | 4.98 | |
| Kala Pharmaceuticals | 11.5 | $12M | 1.5M | 8.27 | |
| Mei Pharma | 9.8 | $11M | 3.5M | 3.07 | |
| Molecular Templates | 8.8 | $9.4M | 1.6M | 5.81 | |
| Garrison Capital | 8.2 | $8.8M | 1.2M | 7.18 | |
| Scynexis | 6.1 | $6.5M | 4.3M | 1.51 | |
| Cm Fin | 5.9 | $6.3M | 857k | 7.38 | |
| Alcentra Cap | 5.6 | $6.0M | 800k | 7.50 | |
| Alerian Mlp Etf | 3.8 | $4.1M | 412k | 10.03 | |
| Spdr S&p 500 Etf (SPY) | 3.7 | $4.0M | 14k | 282.51 | |
| Berkshire Hathaway (BRK.B) | 1.7 | $1.9M | 9.3k | 200.92 | |
| ArQule | 0.7 | $700k | 146k | 4.79 | |
| Eiger Biopharmaceuticals | 0.6 | $689k | 49k | 13.98 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $338k | 277k | 1.22 | |
| Kura Oncology (KURA) | 0.3 | $320k | 19k | 16.60 | |
| Cti Biopharma | 0.3 | $313k | 323k | 0.97 | |
| Ferroglobe (GSM) | 0.3 | $285k | 139k | 2.05 | |
| Marker Therapeutics Ord | 0.3 | $280k | 42k | 6.61 | |
| Fs Investment Corporation | 0.2 | $245k | 41k | 6.06 | |
| Spring Bk Pharmaceuticals In | 0.2 | $249k | 24k | 10.50 | |
| Far Pt Acquisition Corp cl a founders sh | 0.2 | $253k | 26k | 9.94 | |
| MercadoLibre (MELI) | 0.2 | $221k | 435.00 | 508.05 | |
| Dicerna Pharmaceuticals | 0.2 | $230k | 16k | 14.62 | |
| American Tower Reit (AMT) | 0.2 | $216k | 1.1k | 196.90 | |
| Credit Acceptance (CACC) | 0.2 | $208k | 460.00 | 452.17 | |
| TransDigm Group Incorporated (TDG) | 0.2 | $208k | 458.00 | 454.15 |
